The large heterozygous deletion of PMS2 (280,707 bp; spanning exons 2 to 15) found in patient 1 has partial homology with the pseudogenes and, therefore, can impact the cancer risk of this patient and her family members. This evidence concerns the gene PMS2 and cancer.